Tobias Bölling
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Tobias Bölling has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
Iris Ernst
3 shared publicationsNormann Willich
3 shared publicationsBeate Timmermann
2 shared publicationsCarmen Martini
2 shared publicationsChristian Rübe
2 shared publicationsHildegard Pape
2 shared publications
Latest Publications
- 1 January 2013
- Published by Elsevier in Clinical Oncology
- Vol. 25 (1) , 19-26
Management of Bone Tumours in Paediatric Oncology
- 1 January 2013
- Published by Elsevier in Clinical Oncology
- Vol. 25 (1) , 19-26
Management of Bone Tumours in Paediatric Oncology
- 1 December 2011
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 81 (5) , e787-e791
Hypothyroidism After Head-and-Neck Radiotherapy in Children and Adolescents: Preliminary Results of the “Registry for the Evaluation of Side Effects After Radiotherapy in Childhood and Adolescence” (RiSK)
- 1 December 2011
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 81 (5) , e787-e791
Hypothyroidism After Head-and-Neck Radiotherapy in Children and Adolescents: Preliminary Results of the “Registry for the Evaluation of Side Effects After Radiotherapy in Childhood and Adolescence” (RiSK)
- 1 July 2011
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 80 (3) , 840-844
Dose–Volume Analysis of Radiation Nephropathy in Children: Preliminary Report of the Risk Consortium
- 1 July 2011
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 80 (3) , 840-844
Dose–Volume Analysis of Radiation Nephropathy in Children: Preliminary Report of the Risk Consortium
- 26 April 2011
- Published by Springer Nature in Strahlentherapie und Onkologie
- Vol. 187 (5) , 311-315
Retrospective, Monocentric Analysis of Late Effects after Total Body Irradiation (TBI) in Adults
Purpose: Total body irradiation (TBI) is a standard treatment modality within the multidisciplinary approach for allogeneous stem cell or bone marrow transplantation. However, surviving patients are at risk for developing a variety of late sequelae. This analysis aimed to retrospectively characterize late effects after TBI in adults treated in a single center. Patients and Methods: Patients ≥ 18 years treated with fractionated TBI (4–12 Gy) between 1996 and 2008 were included in this study. Treatment data were collected retrospectively from the treating departments. Late effects were evaluated using the clinic charts and/or were obtained from the general practitioners using a standardized questionnaire. Analyses were performed by calculation of the cumulative incidences using the Kaplan–Meier method and the log rank test. Results: A total of 308 patients ≥ 18 years were treated including a TBI of whom 78 patients were excluded from further analysis due to death within less than 1 year after TBI. Patients suffered from leukemia in most cases. Late toxicity follow-up was available in 120 patients (mean age 46.1 years; range, 18–70 years) after a mean follow-up of 23 months (range, 12–96 months). The cumulative incidences (CI) at 3 years were 28% for pulmonary event, 8% for pulmonary toxicity, 25% for kidney toxicity, 8% for cataract, 17% for bone toxicity, and 10% for secondary malignancy. The CI of bone toxicity was higher in female than in male patients (p = 0.019). Conclusion: Late effects after TBI in the context of allogeneous stem cell or bone marrow transplantation can frequently be observed. Regular follow-up examinations are advised for the early registration and treatment of adverse effects.
- 26 April 2011
- Published by Springer Nature in Strahlentherapie und Onkologie
- Vol. 187 (5) , 311-315
Retrospective, Monocentric Analysis of Late Effects after Total Body Irradiation (TBI) in Adults
Purpose: Total body irradiation (TBI) is a standard treatment modality within the multidisciplinary approach for allogeneous stem cell or bone marrow transplantation. However, surviving patients are at risk for developing a variety of late sequelae. This analysis aimed to retrospectively characterize late effects after TBI in adults treated in a single center. Patients and Methods: Patients ≥ 18 years treated with fractionated TBI (4–12 Gy) between 1996 and 2008 were included in this study. Treatment data were collected retrospectively from the treating departments. Late effects were evaluated using the clinic charts and/or were obtained from the general practitioners using a standardized questionnaire. Analyses were performed by calculation of the cumulative incidences using the Kaplan–Meier method and the log rank test. Results: A total of 308 patients ≥ 18 years were treated including a TBI of whom 78 patients were excluded from further analysis due to death within less than 1 year after TBI. Patients suffered from leukemia in most cases. Late toxicity follow-up was available in 120 patients (mean age 46.1 years; range, 18–70 years) after a mean follow-up of 23 months (range, 12–96 months). The cumulative incidences (CI) at 3 years were 28% for pulmonary event, 8% for pulmonary toxicity, 25% for kidney toxicity, 8% for cataract, 17% for bone toxicity, and 10% for secondary malignancy. The CI of bone toxicity was higher in female than in male patients (p = 0.019). Conclusion: Late effects after TBI in the context of allogeneous stem cell or bone marrow transplantation can frequently be observed. Regular follow-up examinations are advised for the early registration and treatment of adverse effects.
- 1 July 2010
- Vol. 30 (7) , 2857-61
Heterogeneity of radiation- and TNF-alpha-induced programmed cell death in carcinoma, sarcoma and lymphoma cell lines.
To characterize the interaction of tumour necrosis factor alpha (TNF-alpha) and ionising radiation in six sarcoma, lymphoma and carcinoma cell lines. Cells were characterized regarding annexin V/propiduim iodine affinity and caspase-3 status after application of TNF-alpha, radiation, or combined treatment. Three cell lines showed similar results with additive effects of TNF-alpha and radiation in both assays. The other three cell lines significantly differed regarding the detection of apoptotic cells between treatment conditions (radiation and/or TNF application) and between the two apoptosis assays. The interaction between TNF-alpha and radiation differs between tumour entities and cannot be described by using only one parameter.
- 1 July 2010
- Vol. 30 (7) , 2857-61
Heterogeneity of radiation- and TNF-alpha-induced programmed cell death in carcinoma, sarcoma and lymphoma cell lines.
To characterize the interaction of tumour necrosis factor alpha (TNF-alpha) and ionising radiation in six sarcoma, lymphoma and carcinoma cell lines. Cells were characterized regarding annexin V/propiduim iodine affinity and caspase-3 status after application of TNF-alpha, radiation, or combined treatment. Three cell lines showed similar results with additive effects of TNF-alpha and radiation in both assays. The other three cell lines significantly differed regarding the detection of apoptotic cells between treatment conditions (radiation and/or TNF application) and between the two apoptosis assays. The interaction between TNF-alpha and radiation differs between tumour entities and cannot be described by using only one parameter.